-During the inflammatory phase of colon cancer, TLR-4 was upregulated in colonic tissues, which promoted tumor development-Blocking TLR-4 with TAK-242 reduced the release of TNF-a and IL-1b. Here, TLR4 is linked to malignant colon neoplasm.